Tune in now to the PhRMA 2016 Annual Meeting

March 9 at 4:00 p.m. marks the start of the PhRMA 2016 Annual Meeting in Washington, D.C.

Josephine MartinMarch 9, 2016

Tune in now to the PhRMA 2016 Annual Meeting.

Today at 4:00 p.m. will mark the start of the PhRMA 2016 Annual Meeting here in Washington, D.C. Click below to watch events so far. 

Over the next two days, we’ll hear from speakers from across the health care spectrum about delivering innovative treatments to patients. From a closer look at personalized medicines as the next health care frontier to policy solutions for our evolving health care system to exploring innovation and the future of medical discovery, the Annual Meeting speakers and panels will foster robust discussion and insight.

Here is a closer look at what we’ll be covering:

Wednesday, March 9, 2016

  • 4:00 p.m. – Chairman’s Welcome and Address, Kenneth C. Frazier, chairman of the board of directors, PhRMA (2015-2016), chairman of the board and CEO, Merck & Co., Inc.
  • 4:15 p.m. – Q&A with Andy Slavitt, acting administrator, Centers for Medicare &Medicaid Services
  • 4:45 p.m. – Personalized Medicine: The Next Health Care Frontier
    Alan J. Balch, Ph.D., CEO, National Patient Advocate Foundation
    Francis S. Collins, M.D., Ph.D., director, National Institutes of Health
    Mikael Dolsten, M.D., Ph.D., president, worldwide research and development, Pfizer Inc.
    Moderated by Amy Miller, Ph.D., executive vice president, Personalized Medicine Coalition

Thursday, March 10, 2016

  • 8:30 a.m. – President’s Address, Stephen J. Ubl, president and CEO, PhRMA
  • 8:45 a.m. – Live Stream Exclusive: Partner Perspectives on Medical Innovation
    Grace-Marie Turner, president, Galen Institute
    Thomas Kowalski, president and CEO, Texas Healthcare & Bioscience Institute
    Stephen Rapundalo, Ph.D., president and CEO, MichBio
    Moderated by Mike Ybarra, M.D., senior director, PhRMA
  • 10:30 a.m. – Innovation: The Future of Medical Discovery
    Jeffrey S. Flier, M.D., dean of the faculty of medicine, Harvard University
    Joseph Jimenez, CEO, Novartis AG
    Kim Thiboldeaux, CEO, Cancer Support Community
    Moderated by
    Andrew C. von Eschenbach, M.D., president, Samaritan Health Initiatives
  • 11:40 a.m. – Closing Address, George A. Scangos, Ph.D., chairman-elect of the board of directors, PhRMA (2015-2016), CEO, Biogen

We hope you’ll tune in and join us in the online conversation using #PhRMA16.


This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.